Mary Lisbeth D’Amico

ACES winner Mirasense is bringing price comparison to the smart phone. The ETH Zurich spin-out is letting users check out what competitors are charging and how previous purchasers rate products, as they shop on the high street

Investment in R&D is surviving spending cuts, but Germany’s innovation policy needs reform and modernisation, say experts.

The German government wants to see 1 million electric vehicles on the roads by 2020. But do investors see a smooth journey ahead?

Philips has invested in Dutch VC Gilde’s new healthcare fund, in what the companies say is a unique cooperation.

German entrepreneur Lars Hinrichs has a new, off-the-peg approach to incubating start-ups. Could this plug the yawning gap in Europe’s venture capital system?

Roland Siegwart plans to build on ETH Zurich's successful start-up ecosystem, improving support and fostering interdisciplinary cooperation.

ACES winner Nikolaos Vlasopoulos is hoping to turn the cement industry upside down with a low-carbon, environmentally friendly variant of the old standby.

With 20 years of experience behind him, ACES winner Nigel Brown believes companies today spend too much money – and energy – on water purification.

Cost conundrum: the investment in clinical trials remains the same but approved drugs will have a smaller market. So how is Personalised Medicine to be financed?

Munich, one of Europe’s top biotechnology clusters, is now setting out to lead the world in personalised medicine.